Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Tissue-type plasminogen activator (tPA) is currently the only U.S. Food and Drug Administration–approved therapy for the acute treatment of ischemic stroke . The most extensively studied function of tPA is its primary activity, namely, the proteolytic conversion of the zymogen…